Composition
- Active ingredients
- EMTRICITABINE 200MG; RILPIVIRINE HYDROCHLORIDE EQ 25MG BASE; TENOFOVIR ALAFENAMIDE FUMARATE EQ 25MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA214095.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Active substance
- emtricitabine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Apotex
- Status
- Prescription
- FDA approval
- 30 Jan 2026
- Application
- ANDA214095-001